GlassScriptPhysician profile
Nishit Choksi
NPI 1992764641
$40,968.81
in general payments reported to CMS, 2019-2025
64 companies · $3,862 in 2025
The $3,862 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,635 · 2020: $3,115 · 2021: $5,266 · 2022: $9,223 · 2023: $6,263 · 2024: $5,606 · 2025: $3,862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $2,585 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,125 · Consulting Fee: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,271.09 |
| Travel and Lodging | $2,584.52 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,125.00 |
| Consulting Fee | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $11,102.99 | 2019-2022 | |
| Edwards Lifesciences Corporation | $6,399.81 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $3,527.77 | 2019-2025 | Esprit, Dragonfly Opstar, Pressurewire |
| Endologix LLC | $3,141.17 | 2019-2025 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System, Torus Stent Graft System |
| Shockwave Medical, INC | $1,991.56 | 2020-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $1,320.42 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,066.30 | 2019-2023 | Xarelto |
| Bard Peripheral Vascular, INC. | $1,057.82 | 2023 | Venclose Maven Catheter |
| Astrazeneca Pharmaceuticals LP | $828.27 | 2020-2025 | Brilinta, Farxiga, Wainua |
| Merck Sharp & Dohme LLC | $811.08 | 2021-2025 | Verquvo |
| Inari Medical, INC. | $785.09 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| E.R. Squibb & Sons, L.L.C. | $776.07 | 2019-2025 | Camzyos, Eliquis |
| Heartflow, INC. | $667.24 | 2022-2025 | Ffrct |
| Boston Scientific Corporation | $597.63 | 2019-2025 | Watchman Flx, Watchman, Watchman Access System |
| Kestra Medical Technology Services, INC. | $459.13 | 2023-2025 | Assure Wcd |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $410.66 | 2019 | |
| Medtronic, INC. | $401.97 | 2021-2025 | Venaseal, Symplicity G3, Onyx Frontier |
| Boehringer Ingelheim Pharmaceuticals, INC. | $385.81 | 2023-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $353.81 | 2019-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $353.05 | 2019-2025 | Opsumit, Uptravi |
| Kiniksa Pharmaceuticals, LTD. | $342.16 | 2021-2023 | Arcalyst |
| Astellas Pharma US INC | $330.52 | 2019-2021 | |
| Pfizer INC. | $301.65 | 2019-2023 | |
| Amgen INC. | $282.55 | 2020-2025 | Repatha, Repatha |
| Terumo Medical Corporation | $264.64 | 2025 | Navicross, Glidewire, Azur Cx Detachable |
| Impulse Dynamics (USA) INC. | $243.55 | 2023 | Optimizer |
| Stryker Corporation | $242.90 | 2025 | Clottriever Bold Catheter, Artix Mt, Ct Thrombectomy System Kit |
| Alnylam Pharmaceuticals INC. | $240.35 | 2022-2025 | Onpattro, Amvuttra |
| Biotronik INC. | $222.08 | 2021-2025 | Orsiro Mission |
| Abiomed | $210.54 | 2021-2025 | Impella |
| Scpharmaceuticals INC. | $158.76 | 2024-2025 | |
| Lexicon Pharmaceuticals, INC. | $132.78 | 2023-2024 | Inpefa |
| Cvrx, INC. | $122.56 | 2021 | |
| Cordis US Corp. | $109.35 | 2023-2025 | Mynx Control, Saber, Zephyr |
| Cagent Vascular INC | $102.88 | 2025 | Serrantor |
| Novo Nordisk INC | $102.25 | 2024-2025 | Wegovy |
| Ablative Solutions, INC. | $101.86 | 2021 | |
| United Therapeutics Corporation | $101.26 | 2023-2025 | Tyvaso, Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $99.22 | 2019-2022 | |
| Chiesi USA, INC. | $92.16 | 2019-2023 | Kengreal |
| Kiniksa Pharmaceuticals International, Plc | $70.15 | 2024 | Arcalyst |
| Cardiva Medical, INC. | $70.06 | 2023-2024 | Cardiva Vascade 6/7f Vcs, Optowire |
| Philips North America LLC | $61.22 | 2023 | |
| Angiodynamics, INC. | $55.75 | 2023 | Alphavac |
| Penumbra, INC. | $50.05 | 2020-2021 | |
| Asahi Intecc USA, INC. | $41.34 | 2022 | |
| Bridgebio Pharma, INC. | $34.45 | 2025 | Attruby |
| Imperative Care, INC | $32.27 | 2025 | Symphony Catheter |
| Lilly USA, LLC | $31.96 | 2025 | Zepbound, Mounjaro |
| Reflow Medical INC | $31.84 | 2024 | |
| Cardinal Health 200 LLC | $30.76 | 2021 | |
| Esperion Therapeutics, INC. | $29.86 | 2024-2025 | Nexletol |
| Medicomp INC | $27.83 | 2025 | Telepatch Cardiac Monitor |
| Irhythm Technologies, INC. | $25.14 | 2022 | |
| Amarin Pharma, INC. | $25.03 | 2020-2021 | |
| Tactile Systems Technology INC | $19.43 | 2025 | Flexitouch Plus, Nimbl |
| Azurity Pharmaceuticals, INC. | $18.76 | 2023 | Edarbi |
| Baxter Healthcare | $17.99 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $17.17 | 2020 | |
| Ibsa Pharma INC. | $13.00 | 2021 | |
| Bardy Diagnostics, INC. | $12.00 | 2021 | |
| Lundbeck LLC | $11.08 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nishit Choksi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.